Clinical Trial Update: Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial on customizing first-line chemotherapy for advanced non-small cell lung cancer has been terminated. The study was sponsored by National…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Guard Health Affairs | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED